scholarly journals In vivo multispectral, multiparameter, photoacoustic lymph flow cytometry with natural cell focusing, label-free detection and multicolor nanoparticle probes

2008 ◽  
Vol 73A (10) ◽  
pp. 884-894 ◽  
Author(s):  
Ekaterina I. Galanzha ◽  
Evgeny V. Shashkov ◽  
Valery V. Tuchin ◽  
Vladimir P. Zharov
2015 ◽  
Author(s):  
Ping Yang ◽  
Rongrong Liu ◽  
Zhenyu Niu ◽  
Yuanzhen Suo ◽  
Hao He ◽  
...  

2016 ◽  
Author(s):  
Xiaoling Wang ◽  
Ping Yang ◽  
Rongrong Liu ◽  
Zhenyu Niu ◽  
Yuanzhen Suo ◽  
...  

2019 ◽  
Vol 12 (06) ◽  
pp. 1930008
Author(s):  
Kai Pang ◽  
Bobo Gu ◽  
Feng Liu ◽  
Mingli Dong ◽  
Lianqing Zhu ◽  
...  

The fluorescence-based in vivo flow cytometry (IVFC) is an emerging tool to monitor circulating cells in vivo. As a noninvasive and real-time diagnostic technology, the fluorescence-based IVFC allows long-term monitoring of circulating cells without changing their native biological environment. It has been applied for various biological applications (e.g., monitoring circulating tumor cells). In this work, we will review our recent works on fluorescence-based IVFC. The operation principle and typical biological applications will be introduced. In addition, the recent advances in IVFC flow cytometry based on photoacoustic effects and other label-free detection methods such as imaging-based methods, diffuse-light methods, hybrid multimodality methods and multispectral methods are also summarized.


2009 ◽  
Vol 69 (20) ◽  
pp. 7926-7934 ◽  
Author(s):  
Ekaterina I. Galanzha ◽  
Evgeny V. Shashkov ◽  
Paul M. Spring ◽  
James Y. Suen ◽  
Vladimir P. Zharov

2021 ◽  
Author(s):  
Zoltán Göröcs ◽  
David Baum ◽  
Fang Song ◽  
Kevin de Haan ◽  
Hatice Ceylan Koydemir ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Serena Van ◽  
Soumiya Pal ◽  
Brittney R. Garner ◽  
Kate Steed ◽  
Vijayalakshmi Sridharan ◽  
...  

Background and Purpose: Doxorubicin (DOX) is a risk factor for arm lymphedema in breast cancer patients. We reported that DOX opens ryanodine receptors (RYRs) to enact “calcium leak,” which disrupts the rhythmic contractions of lymph vessels (LVs) to attenuate lymph flow. Here, we evaluated whether dantrolene, a clinically available RYR1 subtype antagonist, prevents the detrimental effects of DOX on lymphatic function.Experimental Approach: Isolated rat mesenteric LVs were cannulated, pressurized (4–5 mm Hg) and equilibrated in physiological salt solution and Fura-2AM. Video microscopy recorded changes in diameter and Fura-2AM fluorescence tracked cytosolic free calcium ([Ca2+i]). High-speed in vivo microscopy assessed mesenteric lymph flow in anesthetized rats. Flow cytometry evaluated RYR1 expression in freshly isolated mesenteric lymphatic muscle cells (LMCs).Key Results: DOX (10 μmol/L) increased resting [Ca2+i] by 17.5 ± 3.7% in isolated LVs (n = 11). The rise in [Ca2+i] was prevented by dantrolene (3 μmol/L; n = 10). A single rapid infusion of DOX (10 mg/kg i.v.) reduced positive volumetric lymph flow to 29.7 ± 10.8% (n = 7) of baseline in mesenteric LVs in vivo. In contrast, flow in LVs superfused with dantrolene (10 μmol/L) only decreased to 76.3 ± 14.0% (n = 7) of baseline in response to DOX infusion. Subsequently, expression of the RYR1 subtype protein as the presumed dantrolene binding site was confirm in isolated mesenteric LMCs by flow cytometry.Conclusion and Implications: We conclude that dantrolene attenuates the acute impairment of lymph flow by DOX and suggest that its prophylactic use in patients subjected to DOX chemotherapy may lower lymphedema risk.


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Cedric Blatter ◽  
Eelco F. J. Meijer ◽  
Ahhyun S. Nam ◽  
Dennis Jones ◽  
Brett E. Bouma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document